<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01250509</url>
  </required_header>
  <id_info>
    <org_study_id>H11640-29259-03A</org_study_id>
    <secondary_id>K01AT004199</secondary_id>
    <nct_id>NCT01250509</nct_id>
  </id_info>
  <brief_title>Craving and Lifestyle Management Through Mindfulness Study</brief_title>
  <acronym>CALMM</acronym>
  <official_title>Effects of Stress Reduction on Eating, Fat Distribution, and Cell Aging Among Overweight Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mount Zion Health Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a mindfulness-based stress reduction and
      mindful eating program will lead to reductions in abdominal fat and total weight and improve
      cell aging in overweight and obese women compared to a waitlist control group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity is the largest growing epidemic, with about 65% of Americans overweight (Flegal,
      Carroll et al. 2002). Obesity, in particular, abdominal obesity, confers increased risk for a
      host of diseases, including hypertension, Type 2 diabetes, and coronary heart disease,
      resulting in shortened life span (Fontaine, Redden et al. 2003). Psychological stress is
      widely cited anecdotally as a factor that causes people to engage in overeating, and studies
      provide strong evidence that stress can promote obesity. Stress induces selective preference
      of sweet, high-fat food and increases visceral fat depots. The telomere maintenance system
      (telomerase activity and telomere length)are markers of cellular aging and predict mortality
      (Cawthon et al, 2003)and have been linked to both psychological stress and components of the
      metabolic syndrome. The proposed study adapts a program called Mindfulness-Based Stress
      Reduction (MBSR) that has been shown to be effective in a variety of other stress-related
      conditions. Fifty overweight, pre-menopausal women at risk for the Metabolic Syndrome will be
      randomized in a 1:1 distribution to either a 3-month intervention to reduce stress and
      overeating [Craving and Lifestyle Management with Mindfulness (CALMM)] or wait list control
      group. The primary outcome measures include amounts of abdominal fat, weight, and telomerase
      activity. Data from this study are intended to provide pilot data for use in planning a
      larger randomized, controlled trial that will investigate the effects of the CALMM
      intervention on the metabolic and psychological processes assessed in this pilot study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Abdominal Fat</measure>
    <time_frame>Change from Baseline in Abdominal Fat (baseline and 4 months)</time_frame>
    <description>Whole-body dual energy X-ray absorptiometry (DEXA) scans were performed to assess body fat distribution. The DEXA densitometry (GE Healthcare Lunar Prodigy, Madison, Wis, USA) was adjusted to the fan beam mode and EnCore software version 9.15 was used. The primary region of interest was fat tissue from a rectangular region in the abdominal area defined by the upper boundary of the second lumbar vertebra to the lower edge of the fourth lumbar vertebra. The vertical sides were defined as the continuation of the lateral sides of the rib cage.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Change in Weight (baseline and 4 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Telomerase Activity</measure>
    <time_frame>Change from Baseline in Telomerase Activity at 4 months</time_frame>
    <description>Cryopreserved peripheral blood nuclear cells (PBMCs) were thawed and live cells counted using a hemocytometer by the Trypan blue exclusion method. For each sample, an extract of 5000 cells per microliter was made and two concentrations, corresponding to 5000 and 10,000 cells, were assayed for each sample to ensure the assay was in the linear range. Telomerase activity was assayed by the Telomerase Repeat Amplification Protocol (TRAP) using a commercial kit (TRAPeze, Telomerase Detection kit, Upstate/ CHEMICON, Temecula, CA). Baseline and post-intervention samples for the same participant were assayed in the same batch and run on the same gel to eliminate any differences caused by reaction or procedural batch-to-batch variations. Technicians were blind to group assignment. Telomerase activity is defined as 1 unit = the amount of product from one 293T cell/10,000 PBMCs, and was quantified using the software ImageQuant 5.2 (GE Healthcare, Piscataway, NJ).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Psychological Stress (Baseline and 4 Months)</measure>
    <time_frame>Change from Baseline in Psychological Stress</time_frame>
    <description>The 10-item Perceived Stress Scale was used to evaluate perception of stressful events over the past month by using a 5-point Likert scale (0 = never to 4 = very often) (Cohen et al., 1983). The mean of the ten items was used in analysis. Higher scores indicate greater perceived stress.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>CALMM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receiving the 'Craving and Lifestyle Management through Mindfulness' intervention, i.e. program that combines stress reduction with mindful eating practices.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants were waitlisted for the intervention during the experimental phase.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Craving and Lifestyle Management through Mindfulness</intervention_name>
    <description>A preliminary, novel intervention was developed drawing on components from Mindfulness-Based Stress Reduction (MBSR), Mindfulness-Based Cognitive Therapy (MBCT), and Mindfulness-Based Eating Awareness Training (MB-EAT). The intervention program consisted of nine 2.5-hour classes and one 7-hour silent day of guided meditation practice after class 6.</description>
    <arm_group_label>CALMM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pre-menopausal

          -  BMI (25 - 40)

          -  Weight &lt; 300 lbs.

          -  Negative urine glucose test

        Exclusion Criteria:

          -  Inability to provide informed consent

          -  Age &lt; 21 or menopausal as determined by self-report

          -  DSM-IV diagnosis of an eating disorder

          -  Any substance abuse, mental health, or medical condition that, in the opinion of
             investigators, will make it difficult for the potential participant to participate in
             the intervention

          -  Factors that confound relations between stress and eating, including, drug abuse and
             use of medications containing corticosteroids.

          -  Diabetes

          -  Polycystic Ovary Syndrome

          -  CHD

          -  Breastfeeding (due to interference with stress hormone measurement)

          -  Non English speaker

          -  Pregnant as determined by pregnancy test at screening visit or planning to get
             pregnant in the next 6 months

          -  Previous MBSR training and/or current meditation, yoga, or other mind-body practice

          -  Initiation of new class of psychiatric medications in past 2 months.

          -  Currently on a weight loss diet
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elissa Epel, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSF Department of Psychiatry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frederick Hecht, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSF Osher Center for Integrative Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer Daubenmier, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSF Osher Center for Integrative Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF Osher Center for Integrative Medicine</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Baer RA, Smith GT, Allen KB. Assessment of mindfulness by self-report: the Kentucky inventory of mindfulness skills. Assessment. 2004 Sep;11(3):191-206.</citation>
    <PMID>15358875</PMID>
  </reference>
  <reference>
    <citation>Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002 Oct 9;288(14):1723-7.</citation>
    <PMID>12365955</PMID>
  </reference>
  <reference>
    <citation>Epel ES, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell KD, Bell J, Ickovics JR. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med. 2000 Sep-Oct;62(5):623-32.</citation>
    <PMID>11020091</PMID>
  </reference>
  <reference>
    <citation>Oliver G, Wardle J, Gibson EL. Stress and food choice: a laboratory study. Psychosom Med. 2000 Nov-Dec;62(6):853-65.</citation>
    <PMID>11139006</PMID>
  </reference>
  <reference>
    <citation>Boggiano MM, Chandler PC, Viana JB, Oswald KD, Maldonado CR, Wauford PK. Combined dieting and stress evoke exaggerated responses to opioids in binge-eating rats. Behav Neurosci. 2005 Oct;119(5):1207-14.</citation>
    <PMID>16300427</PMID>
  </reference>
  <reference>
    <citation>Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005 Nov 5;366(9497):1640-9.</citation>
    <PMID>16271645</PMID>
  </reference>
  <reference>
    <citation>Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001 Jan;26(1):37-49.</citation>
    <PMID>11070333</PMID>
  </reference>
  <reference>
    <citation>Epel E, Jimenez S, Brownell K, Stroud L, Stoney C, Niaura R. Are stress eaters at risk for the metabolic syndrome? Ann N Y Acad Sci. 2004 Dec;1032:208-10.</citation>
    <PMID>15677412</PMID>
  </reference>
  <reference>
    <citation>Rebuff√©-Scrive M, Walsh UA, McEwen B, Rodin J. Effect of chronic stress and exogenous glucocorticoids on regional fat distribution and metabolism. Physiol Behav. 1992 Sep;52(3):583-90.</citation>
    <PMID>1409924</PMID>
  </reference>
  <reference>
    <citation>Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005 Jan;30(1):1-10. Review.</citation>
    <PMID>15358437</PMID>
  </reference>
  <reference>
    <citation>Roemmich JN, Wright SM, Epstein LH. Dietary restraint and stress-induced snacking in youth. Obes Res. 2002 Nov;10(11):1120-6.</citation>
    <PMID>12429875</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2010</study_first_submitted>
  <study_first_submitted_qc>November 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2010</study_first_posted>
  <results_first_submitted>May 29, 2012</results_first_submitted>
  <results_first_submitted_qc>January 16, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 18, 2013</results_first_posted>
  <last_update_submitted>January 16, 2013</last_update_submitted>
  <last_update_submitted_qc>January 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Mindfulness based stress reduction</keyword>
  <keyword>Mindful eating</keyword>
  <keyword>Stress</keyword>
  <keyword>Overnutrition</keyword>
  <keyword>Nutrition Disorders</keyword>
  <keyword>Overweight</keyword>
  <keyword>Body Weight</keyword>
  <keyword>Signs and Symptoms</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Female participants were recruited through media outlets and flyers posted in the San Francisco Bay Area. Three hundred twenty-two potential participants were screened for eligibility from November 2006 to March 2007.</recruitment_details>
      <pre_assignment_details>Fifty-three met eligibility criteria and chose to enroll, and 47 went on to the randomization stage. Before randomization, 5 participants dropped due to time constaints and 1 dropped due to illness.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>CALMM</title>
          <description>Participants receiving CALMM intervention, i.e. program that combines stress reduction with mindful eating practices.</description>
        </group>
        <group group_id="P2">
          <title>Waitlist Control</title>
          <description>Participants were waitlisted for the intervention during the experimental phase.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CALMM</title>
          <description>Participants receiving CALMM intervention, i.e. program that combines stress reduction with mindful eating practices.</description>
        </group>
        <group group_id="B2">
          <title>Waitlist Control</title>
          <description>Participants were waitlisted for the intervention during the experimental phase.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="47"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.4" spread="8.0"/>
                    <measurement group_id="B2" value="41.4" spread="6.7"/>
                    <measurement group_id="B3" value="40.9" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Abdominal Fat</title>
        <description>Whole-body dual energy X-ray absorptiometry (DEXA) scans were performed to assess body fat distribution. The DEXA densitometry (GE Healthcare Lunar Prodigy, Madison, Wis, USA) was adjusted to the fan beam mode and EnCore software version 9.15 was used. The primary region of interest was fat tissue from a rectangular region in the abdominal area defined by the upper boundary of the second lumbar vertebra to the lower edge of the fourth lumbar vertebra. The vertical sides were defined as the continuation of the lateral sides of the rib cage.</description>
        <time_frame>Change from Baseline in Abdominal Fat (baseline and 4 months)</time_frame>
        <population>Intent-to-treat analyses were conducted. Assuming participants lost to followup did not change over time, missing data at postintervention were imputed using preintervention values.</population>
        <group_list>
          <group group_id="O1">
            <title>CALMM</title>
          </group>
          <group group_id="O2">
            <title>Waitlist</title>
          </group>
        </group_list>
        <measure>
          <title>Change in Abdominal Fat</title>
          <description>Whole-body dual energy X-ray absorptiometry (DEXA) scans were performed to assess body fat distribution. The DEXA densitometry (GE Healthcare Lunar Prodigy, Madison, Wis, USA) was adjusted to the fan beam mode and EnCore software version 9.15 was used. The primary region of interest was fat tissue from a rectangular region in the abdominal area defined by the upper boundary of the second lumbar vertebra to the lower edge of the fourth lumbar vertebra. The vertical sides were defined as the continuation of the lateral sides of the rib cage.</description>
          <population>Intent-to-treat analyses were conducted. Assuming participants lost to followup did not change over time, missing data at postintervention were imputed using preintervention values.</population>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.2" spread="318.9"/>
                    <measurement group_id="O2" value="50.0" spread="305.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weight</title>
        <time_frame>Change in Weight (baseline and 4 months)</time_frame>
        <population>Intention to treat analysis was conducted. Assuming participants lost to followup did not change over time, missing data at postintervention were imputed using preintervention values.</population>
        <group_list>
          <group group_id="O1">
            <title>CALMM</title>
            <description>Participants receiving CALMM intervention, i.e. program that combines stress reduction with mindful eating practices.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants were waitlisted for the intervention during the experimental phase.</description>
          </group>
        </group_list>
        <measure>
          <title>Weight</title>
          <population>Intention to treat analysis was conducted. Assuming participants lost to followup did not change over time, missing data at postintervention were imputed using preintervention values.</population>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="2.7"/>
                    <measurement group_id="O2" value="0.38" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Telomerase Activity</title>
        <description>Cryopreserved peripheral blood nuclear cells (PBMCs) were thawed and live cells counted using a hemocytometer by the Trypan blue exclusion method. For each sample, an extract of 5000 cells per microliter was made and two concentrations, corresponding to 5000 and 10,000 cells, were assayed for each sample to ensure the assay was in the linear range. Telomerase activity was assayed by the Telomerase Repeat Amplification Protocol (TRAP) using a commercial kit (TRAPeze, Telomerase Detection kit, Upstate/ CHEMICON, Temecula, CA). Baseline and post-intervention samples for the same participant were assayed in the same batch and run on the same gel to eliminate any differences caused by reaction or procedural batch-to-batch variations. Technicians were blind to group assignment. Telomerase activity is defined as 1 unit = the amount of product from one 293T cell/10,000 PBMCs, and was quantified using the software ImageQuant 5.2 (GE Healthcare, Piscataway, NJ).</description>
        <time_frame>Change from Baseline in Telomerase Activity at 4 months</time_frame>
        <population>Intention-to-treat analysis was conducted.</population>
        <group_list>
          <group group_id="O1">
            <title>CALMM</title>
            <description>Participants receiving CALMM intervention, i.e. program that combines stress reduction with mindful eating practices.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants were waitlisted for the intervention during the experimental phase.</description>
          </group>
        </group_list>
        <measure>
          <title>Telomerase Activity</title>
          <description>Cryopreserved peripheral blood nuclear cells (PBMCs) were thawed and live cells counted using a hemocytometer by the Trypan blue exclusion method. For each sample, an extract of 5000 cells per microliter was made and two concentrations, corresponding to 5000 and 10,000 cells, were assayed for each sample to ensure the assay was in the linear range. Telomerase activity was assayed by the Telomerase Repeat Amplification Protocol (TRAP) using a commercial kit (TRAPeze, Telomerase Detection kit, Upstate/ CHEMICON, Temecula, CA). Baseline and post-intervention samples for the same participant were assayed in the same batch and run on the same gel to eliminate any differences caused by reaction or procedural batch-to-batch variations. Technicians were blind to group assignment. Telomerase activity is defined as 1 unit = the amount of product from one 293T cell/10,000 PBMCs, and was quantified using the software ImageQuant 5.2 (GE Healthcare, Piscataway, NJ).</description>
          <population>Intention-to-treat analysis was conducted.</population>
          <units>Standard arbitrary units, see above</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.5"/>
                    <measurement group_id="O2" value="0.15" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Psychological Stress (Baseline and 4 Months)</title>
        <description>The 10-item Perceived Stress Scale was used to evaluate perception of stressful events over the past month by using a 5-point Likert scale (0 = never to 4 = very often) (Cohen et al., 1983). The mean of the ten items was used in analysis. Higher scores indicate greater perceived stress.</description>
        <time_frame>Change from Baseline in Psychological Stress</time_frame>
        <population>An intention-to-treat analysis was conducted. Assuming participants lost to followup did not change over time, missing data at postintervention were imputed using preintervention values.</population>
        <group_list>
          <group group_id="O1">
            <title>CALMM</title>
            <description>Participants receiving CALMM intervention, i.e. program that combines stress reduction with mindful eating practices.</description>
          </group>
          <group group_id="O2">
            <title>Waitlist Control</title>
            <description>Participants were waitlisted for the intervention during the experimental phase.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Psychological Stress (Baseline and 4 Months)</title>
          <description>The 10-item Perceived Stress Scale was used to evaluate perception of stressful events over the past month by using a 5-point Likert scale (0 = never to 4 = very often) (Cohen et al., 1983). The mean of the ten items was used in analysis. Higher scores indicate greater perceived stress.</description>
          <population>An intention-to-treat analysis was conducted. Assuming participants lost to followup did not change over time, missing data at postintervention were imputed using preintervention values.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.20" spread="0.5"/>
                    <measurement group_id="O2" value="0.03" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>CALMM</title>
          <description>Participants receiving CALMM intervention, i.e. program that combines stress reduction with mindful eating practices.</description>
        </group>
        <group group_id="E2">
          <title>Waitlist Control</title>
          <description>Participants were waitlisted for the intervention during the experimental phase.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jennifer Daubenmier, PhD</name_or_title>
      <organization>University of California, San Francisco</organization>
      <phone>415-514-8601</phone>
      <email>jennifer.daubenmier@ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

